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1. Glossary 
 
ATM: Ataxia Telangiectasia Mutated  
ATR: ATM and RAD3-related 
BrdU: Bromodeoxyuridine 
CDK: Cycline dependent kinase 
Chk1: Checkpoint kinase 1 
Chk2: Checkpoint kinase 2 
Cip/Kip: CDK interacting protein/Kinase inhibitory protein 
Cy3-dCTP: Deoxycytidine triphosphate coniugated with Cy3 
fluorescent dye 
dATP: Deoxyadenosine triphosphate 
dCTP: Deoxycytidine triphosphate 
dDK: Deoxyribonucleoside kinases 
dCK: Deoxycytidine kinase 
dGK: Deoxyguanosine kinase 
dGTP: Deoxyguanosine triphopshate 
dNTP: Deoxynucleotide triphophate 
DSB: Double strand breaks 
dTTP: deoxythymidine triphosphate 
G1: Gap1 
G2: Gap 2 
GdR: Deoxyguanosine 
GF: Grow factor 
HSE: High speed extracts 
INK4: Inhibitor of CDK4 
LSE: Low speed extracts 
M: Mitosis 
MPF: M-phase promoting factor 
MSC: Muscle satellite cells 
Mt: Myotubes 
NDPK: Nucleoside diphosphate kinase 
NdR: Deoxyribonucleosides  
NMPK: Nucleoside monophosphate kinase 
P: Proliferating myoblasts 
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PI3K family: Phosphatidylinositol 3-kinase-related kinase protein 
family 
pRb: Retinoblastoma protein 
Q: Quiescent myoblasts 
R point: Restriction point 
rMt: Reactivated myotube by siRNA p21 and p27 
RNR: Ribonucleotide reductase 
S: Synthesys 
SAMHD1: Sterile Alpha Motif and HD-domain containing protein 
TD: Terminally differentiated 
TdR: Deoxythymidine 
TK1: Thymidine kinase 1 
TK2: Thymidine kinase 2 
XEE: Xenopus egg extracts 
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2. SUMMARY 
 
Terminally differentiated (TD) cells are characterized by the 
permanent inability to proliferate. In culture, skeletal muscle 
myotubes (Mt), a model system of TD, can be forced to reenter the 
cell cycle by several means, including expression of adenovirus 
E1A, overexpression of cyclin D1 and CDK4/6, or depletion of 
CDK inhibitors. Nonetheless, cell cycle reactivation in Mt never 
results in a long-term survival and effective proliferation. 
Reactivated Mt suffer heavy DNA damage, and die by apoptosis or 
mitotic catastrophe. Critically, they are not able to fully duplicate 
their DNA.  
The purpose of this thesis is to understand the molecular bases that 
prevent Mt to lead a regular and complete replication.  
We investigated through functional (i.e., biochemical) problems 
and structural obstacles.  
Functionally, we found that Mt attempt to duplicate their DNA 
with extremely low levels of deoxythimidine triphosphate (dTTP). 
This is explained by failure to upregulate thymidine kinase (TK) 
upon cell cycle reentry. Exogenous administration of 
deoxythymidine or expression of TK increased DNA synthesis, 
though it never attained completion. 
We then used Xenopus laevis egg extracts (XEE) to study DNA 
replication in nuclei from Mt and proliferating (P) or quiescent (Q) 
myoblasts. XEE are able to complement any functional defect, 
highlighting structural obstacles. Maximal DNA replication in Mt 
nuclei was strikingly lower than in those from Q and P myoblasts, 
revealing the presence of a barrier that prevent Mt to replicate the 
whole genome. To investigate at which level of nuclear complexity 
this obstacle lies, we studied replication kinetics in naked and 
nucleosome-assembled DNA from Mt, in comparison with  similar  
samples from P myoblasts. Together, all results showed that both 
functional and structural obstacles prevent full DNA duplication in 
myotubes. Furthermore, they suggest that hitherto unexplored 
peculiarities of their chromatin are ultimately responsible for the 
inability of these cells to proliferate. 
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3. INTRODUCTION 
 
3.1. THE CELL CYCLE 
 
The eukaryotic cell cycle is an ordered and regulated series of 
events that leads to the production of two daughter cells. It consists 
of two consecutive processes, mainly characterized by DNA 
replication and segregation of replicated chromosomes into two 
separate cells. Cell division can be subdivided into 4 traditional 
stages: Gap1 (G1), Synthesis (S), Gap2 (G2) and mitosis (M). The 
interlude between two M phases is defined interphase, period in 
which a cell spends most of its life cycle. In G1 phase cells increase 
in size and prepare the next stage, synthesizing proteins necessary 
for DNA replication. During the S phase the amount of DNA 
doubles, whereas the transcription of RNA and protein synthesis 
decrease. The G2 phase is characterized by rapid cell growth and 
strong protein synthesis. In mitosis the pairs of chromosomes 
condense and attach to fibers that pull the sister chromatids to 
opposite sides of the cell, in order to divide the nucleus. After this 
stage the cytokinesis occurs, leading to the division of the 
cytoplasm and the birth of two daughter cells with equal genome.  
If a cell is subjected to adverse environmental conditions for 
replication, it may stop the cell cycle at the G1 stage and enter a 
phase of relax, called G0 (Baserga, R., and Rubin, R., 1993). This 
break may be reversible (typical of quiescence) or physiologically 
irreversible (typical of terminal differentiation). Even upon 
favorable conditions, however, the cell cycle cannot be repeated 
limitless. The number of duplications that a cell can perform is 
known as the Hayflick limit (Hayflick, L., 1965), from the name of 
the researcher who put in evidence this phenomenon, beyond 
which the cell becames senescent. Different cellular proteins, such 
as cyclins and cyclin-dependent kinases (CDK), are necessary to 
regulate the transistions above mentioned.  
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3.1.1. CYCLINS AND CYCLIN-DEPENDENT KINASES 
The cyclin-dependent kinases (CDK), are a family of protein that 
can phosphorylate target substrates at specific serine or threonine 
sites. Until now, nine CDK have been identified and, of these, five 
are active during the cell cycle, i.e. during G1 (CDK4, CDK6 and 
CDK2), S (CDK2), G2 and M (CDK1). When activated, CDK 
induce downstream processes by phosphorylating selected proteins 
(Morgan 1995; Pines 1995). The expression of CDK is relatively 
constant during the cell cycle and their regulation depends mainly 
on the availability of cyclins, phosphorylation and 
dephosphorylation events and the presence of specific inhibitors 
(Ekholm, S.V., and Reed, S.I., 2000). Cyclins are proteins which 
levels rise and fall during the cell cycle and in this way they 
periodically activate CDK (Evans et al. 1983; Pines 1991). 
During the transition from G0 to G1 phase, mitogenic signals 
converge primarily on the expression, assembly and activation of 
cyclin D/CDK complexes. Three cyclins D (D1, D2, D3) are 
known. They are expressed differently in different organs and 
tissues (Sherr, C.J., 1993). All the cyclins D can assemble with 
CDK4 or CDK6, causing a connection between the mitogenic 
signaling and the machinery of the cell cycle (Ekholm, S.V., and 
Reed, S.I., 2000). The progression of G1 depends on the continous 
expression of these cyclins which, in turn, rely on mitogenic 
stimulation. There is a specific point of G1 called "restriction point" 
(R point), beyond which the cell becomes independent of growth 
factors. The cyclin D/CDK complexes are no longer required until 
the conclusion of the cell division cycle and the following re-entry 
in the next G1 phase (Matsushime, H. et al., 1994). Cyclin D/CDK 
phosphorylates and inactivates the retinoblastoma protein (pRb), 
p107 and p130. Once phosphorylated, these proteins release factors 
belonging to the E2F family, which activate the transcription of 
some genes necessary for the beginning of S phase, for the 
metabolism and the DNA replication (Trimarchi, J.M., and Lees, 
J.A., 2002). Cyclin D/CDK complexes have, also, a non-catalytic 
role in the progression of G1 phase: they sequester specific cell 
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cycle inhibitors, releasing and activating the cyclin E/CDK2 
complex, typical of the late G1 phase (Sherr, C.J., and Roberts, 
J.M., 1995). The activity of cyclin E/CDK2 reaches its peak in the 
G1/S transition of the cell cycle (Dulic, V. et al., 1992) decreasing 
rapidly in the early S phase, due to degradation by the proteasome 
(Welcker, M. et al., 2003). This complex can phosphorylate many 
proteins, among which pRb (in different sites than those 
recognized by cyclins D/CDK), and can regulate various substrates 
involved in the expression of histone genes, in the duplication of 
centrosomes and in the DNA replication (Yu, Q., and Sicinski, P., 
2004). CDK2 can, also, forms complexes with cyclin A.   
Cyclin A is involved in the progression from G1 to S phase. The 
levels of this protein are high in S and G2 phase and declines in 
early mitosis when it is degraded (Sherr, C.J., and Roberts, J.M., 
1995).   There are known two types of cyclin A (A1 and A2): 
cyclin A1 is expressed only in early embryonic stages of meiosis 
and in some types of cancer (Liu, D. et al. , 1998), while the cyclin 
A2 is present in all somatic proliferating cells (Murphy, M. et al., 
1997). 
The kinase activity of the cyclin A/CDK2 complex is exerted on 
substrates triggering the DNA replication (Coverely, D. et al., 
2002) and on molecules which coordinate the end of S phase with 
the activation of the mitotic CDK (Mitra, J., and Enders, G.H., 
2004). 
Cyclin A can also regulate CDK1. The role of cyclin A-CDK1 in 
mitosis is poorly characterized and appears to be involved in the 
proper assembly of the complexes recognizing the origins of 
replication on chromatin (Li C.J. et al., 2004). 
The cyclins B, called "mitotic cyclins" (Fung, T.K., and Poon, 
R.Y.J., 2005), bind CDK1 forming a complex called "M-phase 
promoting factor" (MPF). MPF phosphorylates and regulates 
fundamental substrates for the entry into mitosis (Fung, T.K., and 
Poon, R.Y.J., 2005). 
Cyclins B begin to be expressed during S phase, reaching a peak in 
the G2/M transition. Their degradation, just before the anaphase 
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(Fung, T.K. and Poon, R.Y.J., 2005), is required for the completion 
and exit from mitosis (Yam, C.H. et al., 2002). 
There are known three types of cyclins B: B1, B2 and B3. Cyclins 
B1 and B2 are expressed in most proliferating cells and have a 
different cellular location: cyclin B1 colocalizes with microtubules, 
cyclin B2 is associated to the Golgi apparatus. The expression of 
cyclin B3, instead, is limited to the germline (Jackman, M. et al., 
1995). 
 
Figure 3.1 Exemplification of cell cycle and its regulators.  
 
 
3.1.2. INHIBITORS OF CYCLIN-DEPENDENT KINASES 
 
The kinase activity of the cyclin/CDK complex is regulated by 
inhibitory proteins called "Cyclin-dependent kinase inhibitors" 
(CKI). CKI inhibit CDK binding them directly or blocking the 
access of the substrate (or the ATP) to the kinase (Pavletich, N.P., 
1999). In relation to their molecular structure and binding 
specificity, these inhibitors are divided into two families: the INK4 
(from "Inhibitor of CDK4") and the Cip/Kip (from "CDK 
interacting protein/kinase inhibitory protein"), (Sherr, C.J. et al., 
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1999). Proteins belonging to the family INK4 are: p15 (Hannon, 
G.J., and Beach, D., 1994), p16 (Serrano, M. et al., 1993), p18 
(Guan, K.L. et al., 1994; Hirai, H. et al., 1995) and p19 (Cham, 
F.K.M. et al., 1995; Hirai, H. et al., 1995). Such inhibitors have 
multiple repetitions of ankyrin and bind only CDK4 and CDK6 
preventing them to assembly with cyclins D (Sherr, C.J., and 
Roberts, J.M., 1999) and blocking the progression of the G1 phase. 
The inhibitors family Cip/Kip include p21 (Gu, Y. et al., 1993; 
Harper, J.W. et al., 1993; El-Deiry, W.S. et al., 1993; Xiong, Y. et 
al., 1993; Dulic, V. et al., 1994; Noda, A. et al., 1994), p27 
(Polyak, K. et al., 1994a, b; Toyoshima, H., and Hunter, T., 1994) 
and p57 (Lee, M.H. et al., 1995; Matsuoka, S. et al., 1995). These 
proteins can bind indifferently to CDK or cyclins, but with a 
greater affinity for the cyclin/CDK complex (Harper, J.W., 1997). 
The Cip/Kip inhibitors have no particular specificity for one 
cyclin/kinase complex and for this reason they play an important 
role in the regulation of all the phases of the cell cycle. It is 
described that these inhibitors are also able to facilitate the 
formation and the consequent activation of the same cyclin/CDK 
complex (Labear, J. et al., 1997); the balance between the activator 
and inhibitor activity is still a subject of debate. The most popular 
theory asserts that the different roles can depend on the 
concentration of these molecules: low levels seem to stimulate, 
while high levels appear to inhibit the activity of cyclin-CDK 
complexes. It, also, seems that different sites of binding (on cyclin 
or on kinase) may be involved in different functions (Nabel, E.G., 
2002). In any case, INK4 and Cip/Kip implement a negative 
control of cell proliferation and deregulative events against these 
molecules play an important role in carcinogenesis (Harper, J.W., 
and Elledge, S.J., 1996). 
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3.1.3.  CHECKPOINTS 
 
In order to ensure a faithful transmission of the genome to 
subsequent generations, preventing errors that can generate 
genomic abnormalities, the cell have developed several 
"checkpoints’ (control points), which guarantee the successful 
completion of the current cell cycle phase before going through the 
next. These checkpoints can be activated as a result of DNA 
damage and are able to temporarily arrest the cell cycle allowing 
repair complexes to correct errors. If the cell fails removing the 
errors, a programmed cell death (apoptosis) occurs. The escape 
from apoptosis causes cell survival and, thus, the establishment of 
the damage and genomic instability, a key step for the neoplastic 
transformation (Murray, A.W., 1992). Four main control points are 
distinguished. The first checkpoint, which controls the passage 
through the G1 phase, is called Restriction Point (R-point) and, as 
mentioned above, responds to growth factors and to the subsequent 
hyperphosphorylation of pRb by cyclin D/CDK4-6 complexes. R-
point is the crucial control point which determines whether or not a 
cell can enter the cell cycle (Foster, D.A. et al., 2010). The 
checkpoint regulating the beginning of S phase (G1/S transition) is 
important for the control of DNA integrity before its replication, 
while the checkpoint that controls the entry into M phase (G2/M 
transition) bypasses the start of mitosis when a damage is detected 
or when the DNA replication is incorrect (Agarwal, M.L., et al., 
1995). Finally, the checkpoint of the M phase 
(metaphase/cytokinesis) monitors the correct segregation of 
chromosomes, examining the right interaction between the mitotic 
spindle and chromosomes and their proper alignment along the 
metaphase plate (Nigg, E.A., 2001). The response to DNA damage 
is implemented by complex mechanisms that include sensors, 
transducers and effectors (Zhou, B.B., and Elledge, S.J., 2000). 
The sensors are proteins that perceive the damage and report it to 
the transducers, which amplify the signal and recruit effectors that 
block the cell cycle, and when it is possible, repair the damage. A 
class of sensors is composed by molecules belonging to 
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phosphatidylinositol 3-kinase-related kinase protein family (PI3K): 
Ataxia Telangiectasia Mutated (ATM) and ATM and RAD3-
related (ATR) (Abraham, R.T., 2001). ATM responds mainly to 
double-strand breaks (DSB), often caused by ionizing radiation, 
while ATR responds to single-strand DNA caused by stalled 
replication forks (Shiloh, Y., 2003). Downstream of ATR and 
ATM, there are the Chk1 and Chk2 kinases ("Checkpoint kinase 1 
and 2"), which modulate the activity of several cell cycle 
regulatory proteins, such as Cdc25 (phosphatase that activates 
cyclin-CDK complexes), p53 (a key protein which regulates 
apoptosis and repair), H2AX (whose phosphorylation is important 
for the correct removal of damages). The immediate consequence 
of checkpoint activation is therefore the cell cycle arrest in G1, S or 
G2/M, depending on when the damage occurred, allowing the cell 
to repair the error or to activate apoptotic mechanisms. (Lukas, J. 
et al., 2004). 
 
3.2.  NO PROLIFERATIVE STATES 
 
Most of the cells that constitute an adult organism do not 
proliferate. They exit from the cell cycle entering in G0 phase. 
Quiescent cells are able to revert this state, while terminally 
differentiated or senescent cells remain permanently in a no 
proliferative state. 
 
3.2.1.  QUIESCENCE 
 
The quiescence is a temporary and reversible absence of 
proliferation. This cellular stage can occur in deprivation of growth 
factors, or when a cell looses the anchoring systems to the 
extracellular matrix or when it is inhibited by the contact with 
other cells. These situations arrest the proliferation in a different 
way, regulating a specific set of genes at trascriptional level. The 
modification of gene expression must constantly be maintained to 
ensure the permanent exit from the cell cycle (Coller, H.A. et al., 
2006). For example, the absence of growth factors leads to a rapid 
Sara Zribi 
 
Pag 16  
reduction of cyclins D expression (Guo, Y. et al., 2005). The arrest 
provoked by contact inhibition is determined by an increase in the 
levels of p27 without reduction of cyclin D (Polyak, K. et al., 
1994; Hengst, L., and Reed, S.I., 1996). To restore proliferation it 
is sufficient removing the cause that determines the permanence in 
G0 (Ekholm, S.V., and Reed, SI, 2000; Sherr, C.J., and Roberts, 
J.M., 2004 ). The quiescent fibroblasts, for example, have low 
levels of cyclins and CDK. After stimulation with growth factors, 
these levels return readily at the original concentration promoting 
fibroblasts to reenter the cell cycle (Kerkhoff, E., and Rapp, U.R., 
1997; Ekholm, S.V., and Reed, S.I., 2000). It is known that the 
activity of cyclins and CKI in G1 phase is to modulate pRb. 
Interestingly, pRb is not required for the induction of quiescence 
(Sage, J. et al., 2000), but its ablation reactivates quiescent and 
senescent cells (Sage, J. et al., 2003) demonstrating that the 
mechanism stimulating quiescence is partially different from that 
which maintains it.  
 
3.2.2. REPLICATIVE SENESCENCE 
In culture, fibroblasts can reach a maximum of 50 cell divisions 
before becoming senescent. This phenomenon is known as 
"replicative senescence", or the Hayflick limit  (Hayflick, L., and 
Moorhead, PS, 1961). Replicative senescence is, thus, a state in 
which cellular proliferation is permanently arrested. It appears to 
be a fundamental feature of somatic cells, with the exception of 
most tumor cells and certain stem cells. Senescence (or cellular 
aging) occurs in response to different conditions, including the 
shortening of telomeres (terminal regions of chromosomes 
consisting of highly repeated DNA), DNA damage and oncogenes 
activation (Herbig, U. et al., 2004; Serrano, M. et al., 1997; 
Bartkova, J. et al., 2006). Unlike quiescence, in cellular aging the 
reduction of protein levels of cyclin D1 and cyclin E does not 
occur. These cyclins are able to bind their CDK, but the association 
generates an enzymatically inactive complex (Dulic, V. et al., 
1993). It has been described that removing the tumor suppressor 
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p53 (Bischoff, F.Z. et al., 1990) or pocket proteins (pRb, p107, 
p130) (Shay, J.W. et al., 1991; Sage, J. et al., 2003) can prevent 
replicative senescence. p21 and p16 protein levels increase with 
the onset of senescence (Tahara, H. et al., 1995; Alcorta, D. et al., 
1996). Furthermore, lowering the levels of these inhibitors can 
slow down the cellular aging before its onset or facilitate the 
process of immortalization (Brown, J.P. et al., 1997). In senescent 
cells, despite the presence of large amounts of cyclins, CDK are 
maintained in an inactive state by prevailing levels of CKI. The 
fundamental importance of CKI for maintaining replicative 
senescence has been confirmed by the discovery that the 
suppression of p21 or p16 induces proliferation in senescent cells 
(Pajalunga, D. et al., 2007a). 
 
3.2.3.  TERMINAL DIFFERENTIATION 
 
The terminal differentiation is a post-mitotic state physiologically 
irreversible. This condition characterizes the cells that are no 
longer able to proliferate since they carry out highly specific 
functions, assuming particular morphological characteristics. In 
extreme cases, such as that of keratinocytes and erythrocytes, the 
terminally differentiated cells (TD) eliminate their nucleus, losing 
irreversibly the ability to divide. Other examples of TD cells are 
neurons, skeletal and heart muscle cells, adipocytes. The inability 
of TD cells to proliferate is an obstacle to the survival of tissues 
without a stem cell compartment. These tissues are particularly 
susceptible to cell loss caused by the onset of disease (Latella, L. et 
al., 2001). The molecular mechanisms that maintain the post-
mitotic state are not fully elucidated. During terminally 
differentiation, G1 phase cyclins decrease, while the levels of CKI 
increase in comparison to that found in proliferating cells 
(Kranenburg, O. et al., 1995). Thus, the balance is inclined towards 
the arrest of proliferation, allowing TD cells to withstand different 
mitogenic stimuli (Tiainen, M. et al., 1996). 
 
 
Sara Zribi 
 
Pag 18  
3.2.3.1.  MUSCLE DIFFERENTIATION 
 
The skeletal muscle cells represent the classic example of terminal 
differentiation and an excellent experimental model due to their 
ease of growth in vitro. Different myogenic cell lines (myoblasts)  
are available and they can terminally differentiate when subjected 
to suitable conditions of growth. In the presence of a culture 
medium devoid of mitogenic signals or following contact 
inhibition, myoblasts exit irreversibly from the cell cycle and start 
to express a large number of muscle-specific genes becoming 
myocytes TD (Okazaki, K., and Holtzer, H., 1966). This ease of 
growth has allowed the performance of numerous studies to 
elucidate the mechanisms responsible for the induction and 
maintenance of muscle differentiation. The genes expressed during 
terminal differentiation include transcription factors of MyoD 
family (as Myf-5, myogenin, MRF-4) and numerous structural 
genes, as the myosin heavy chain and the muscle creatine kinase 
(Weintraub, H. et al., 1991). 
MyoD is expressed in proliferating myoblasts, but it is inactivated 
by the presence of growth factors in the culture medium. Following 
deprivation of mitogenic factors, MyoD exerts its transcriptional 
activity on the promoters of specific muscle target, in particular 
p21 (Halevy, O. et al., 1995) and pRb (Martelli, F. et al., 1994). In 
skeletal muscle cells it has been shown that pRb plays a key role in 
the induction of the post-mitotic state, but not in its maintenance: 
the removal of the protein by terminal differentiated myotubes 
does not suppress the post mitotic status of these TD cells 
(Camarda, G. et al., 2004). This observation leads to distinguish 
permanently TD cells from those quiescent and senescent, where 
the maintenance of mitotic arrest depends on pRb. As opposed, the 
presence of p21 is not essential for the induction of muscle 
differentiation (Figliola, R., and Maione, R., 2004), but its activity 
is essential for myogenic maintenance (Pajalunga et al., 2007). The 
action of MyoD leads to the exit from the cell cycle. The cells 
become myocytes and fuse generating multinucleated cells called 
myotubes (Mt) (Okazaki, K., and Holtzer, H., 1966). During the 
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differentiation of skeletal muscle, the levels of cyclins D1, A, B are 
early lowered (Ohkubo, Y. et al., 1994; Tiainen, M. et al., 1996b)) 
while rapidly the levels of some CKI rise. It has been seen that 
there is a close correlation between the increase of many CKI and 
terminal differentiation of myotubes (Zabludoff, S.D. et al., 1998). 
Today it is clear that the cell cycle inhibitors have a role to 
maintain the proliferative block in skeletal muscle cells TD 
(Pajalunga, D. et al., 2007a). Several studies have found high 
levels of one or more CKI also in other terminally differentiated 
cell types, for example in granulocytes (Steinman, R.A. et al., 
1994; Jiang, H. et al., 1994), in keratinocytes (Missero, C. et al., 
1995), in oligodendrocytes (Durand, B. et al., 1997), in neurons 
and cardiomyocytes (Gill, R.M. et al., 1998; Zindy, F. et al., 1999), 
in adipocytes (Morrison, R.F., and Farmer, SR, 1999) and in 
plasma cells (Tourigny, M.R. et al., 2002). Despite the essential 
role of CKI in maintaining postmitotic state was assumed, the 
evidence in support of this thesis has been only correlative for a 
long time (Halevy, O. et al., 1995; Parker, S.B. et al., 1995).  
 
3.2.4. CELL CYCLE REACTIVATION OF TERMINALLY 
DIFFERENTIATED CELLS 
 
The terminally differentiated cells are totally unable to divide. 
However, this does not imply that they are refractory to 
proliferative stimuli. It was shown that myotubes stimulated with 
serum can exit from G0 phase (Tiainen, M. et al., 1999), since they 
are able to increase early G1 genes (c-myc, c-fos, c-jun, Id-1) 
expression, and then cyclin D1 levels. While quiescent myoblasts 
stimulated with serum proceed along the cell cycle expressing the 
late G1 genes (cyclin E, PCNA, B-myb and cyclin A), myotubes 
are blocked in mid G1 phase failing to raise protein levels of the 
late positive regulators (Tiainen, M. et al., 1996). Myotubes can 
reenter the cell cycle following the expression of retroviral 
oncogenes, which are not able to induce the S phase yet (Tiainen, 
M. et al., 1996). The re-entry into S phase does not take place even 
after the expression of high levels of E2F protein or cyclin 
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E/CDK2 complexes (key regulators for the G1/S transition) 
(Pajalunga, D. et al., 1999). 
It has been shown that TD cells, although physiologically 
refractory to proliferation, can be "forced" to synthesize DNA 
following the expression of DNA tumoral viruses oncogenes, such 
as SV40 Large T (Endo, T., and Nadal Ginard, B., 1989) or 
Adenovirus E1A  (Crescenzi, M. et al., 1995). The oncogene E1A 
overcomes the block in G1 phase, acting directly in the G1/S 
transition. In myotubes infected by adenovirus, there is an increase 
in the levels of the late G1 genes (cyclin E, PCNA, B-myb, cyclin 
A), but the early G1 genes are not upregulated (c-fos, c-myc, Id-1 
and cyclin D1). In several attempts to reactivate the cell cycle in 
TD cells, there was the important discovery that many terminally 
differentiated cell types (myotubes, neurons and adipocytes) can 
return to synthesize DNA by overexpressing cyclin D1/CDK4 
complexes (Latella, L. et al., 2001). The activity of the cyclin 
D/CDK4-6 complex after the exogenous expression of both 
proteins was comparable to the levels found in proliferating 
myoblasts. This result suggests that the principal reason behind the 
inability of myotubes to proliferate is due to the tight negative 
control exercised by CKI over CDK4-6 kinases. Previous results 
strongly indicate that the high levels of cyclin D1 and CDK4-6 
required for efficient induction of S phase are necessary to titrate 
the excess of CKI, in particular p21, p27 and p57 present in 
myotubes (Pajalunga et al., 2007). Moreover, the elevated 
expression of cyclin E/CDK2 complex, whose action follows the 
activation of cyclin D/ CDK4-6, does not produce the same result 
(Pajalunga, D. et al., 1999), suggesting that the cell cycle re-entry 
must involve mainly the activation of CDK4 and CDK6 (Latella, 
L. et al., 2001). 
Recently it has been shown that it is possible to induce the 
reactivation of the cell cycle and DNA synthesis in postmitotic 
cells, quiescent, senescent or TD, by the removal of specific CKI, 
in the absence of growth factors. Consequent to this removal, the 
kinase activity associated with the cyclin D/CDK4-6 complex is 
restored. This result leads to reconsider the fundamental role of the 
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above mentioned kinases in cell differentiation: their activities 
must be down regulated to reach postmitotic state and, vice versa, 
they should be restored to overcome the proliferative block. These 
results indicate also that both the reversible and irreversible 
proliferative arrest are determined by the execution of an active 
common molecular program, which requires the constant 
expression of the cell cycle inhibitors (Pajalunga, D. et al., 2007). 
Despite the successes achieved in TD cells, their proliferation is 
currently impossible, regardless of the method used to obtain the 
reactivation. In particular, myotubes die following cell cycle 
reactivation by SV40 Large T (Endo, T., and Nadal-Ginard, B., 
1989) or E1A (Latella, L. et al., 2001) expression or by CKI 
inhibition (Pajalunga, D. et al., 2007), while the inner ear cells are 
vulerable to cell death after the expression of E7 of HPV (Sulg, M. 
et al., 2009). It was found that muscle TD cells, unlike the 
quiescent cells, are intrinsically unable to complete chromatin 
replication (Fig. 3.2) 
Reactivated myoutubes suffer DNA damage (Fig. 3.3) closely 
related to the beginning of S phase. They can die by apoptosis or 
be stopped in the G2 phase (Pajalunga, D. et al., 2010).  
Examples of proliferative arrest in G2 include myotubes reactivated 
by cyclin D1/CDK4 expression and cardiomyocytes reactivated 
through E1A, E2F1 (Kirshenbaum, L.A. et al., 1996) or the 
intracellular domain of Notch2 expression (Campa, V.M. et al., 
2008). Sometimes reactivated muscle TD cells (by CKI depletion o 
E1A expression) can enter in M phase, but unfortunately they have 
catastrophic mitosis (Fig.3.4). 
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Figure 3.2 Immunofluorescence for BrdU.  Reactivated myotubes by siRNA against 
p21 and p27 proteins, show an alterated pattern of BrdU incorporation (green) in 
comparison to the homogenous pattern of proliferating myoblasts (Pajalunga, D. et 
al., 2010). 
 
 
Figure 3.3 Immunofluorescence for γ-H2AX. Reactivated myotubes by siRNA 
against p21 and p27 proteins, are affected by DNA damage as reflected by the 
phosphorylation of histone H2AX (red) (S.Z. unpublished data). 
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Figure 3.4 Immunofluorescence. Mitotic catastrophes of reactivated myotubes by 
siRNA against p21 and p27 proteins (Pajalunga, D. et al., 2010).  
 
The reasons behind the persistent inability of TD cells to 
proliferate are object of study. DNA damage may be the cause or 
the effect of the partial genome replication. On one side it is 
possible that, following the replication attempt, the chromosomal 
damage may cause the activation of S-phase checkpoint and thus 
the arrest of DNA replication (Godfrey, V., and Prives, C. , 2005). 
Alternatively, the incomplete replication of DNA could be ascribed 
to the special characteristics of myotubes (as a particular 
organization of chromatin). Forcing DNA synthesis through 
structural obstacles could cause damage.  
 
3.3. THE DEOXYRIBONUCLEOSIDE TRIPHOSPHATES 
(dNTPs) 
To replicate their DNA and repair genomic lesions, mammalian 
cells require a balanced amount of the DNA precursors, the 
deoxyribonucleoside triphosphates (dNTPs); the two purine 
nucleotides: the deoxyadenosine triphosphate (dATP) and the 
deoxyguanosine triphosphate (dGTP); and the two pyrimidine 
nucleotides: the deoxycytidine triphosphate (dCTP) and the 
deoxythymidine triphosphate (dTTP). During S phase, dNTP pool 
increase from 20 to 30 folds and it is characterized by an elevated 
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turnover. In the other phases of the cell cycle the amount of dNTPs 
decrease, but is sufficient to support nuclear DNA repair and the 
mitochondrial DNA replication (Bogenhagen, D.F. and Clayton, 
D.A., 1976). The quantitative ratio between the individual 
nucleotides is fundamental to accurately replicate DNA. Thus, it 
was demonstrated that an imbalance of dNTP pool provokes a 
reduced fidelity in the chromatin replication leading to mutations, 
chromosomal aberrations and mutagenesis (Kunz, B.A. and 
Köhalmi, S.E., 1991; Kunz, B.A. et al., 1994). 
 
3.3.1.  METABOLIC PATHWAYS 
 
dNTPs production occurs through two distinct via (Reichard, P., 
1988): the de novo synthesis (neo-synthesis) and the salvage 
pathway (recovery). The de novo synthesis occurs cytoplasmically. 
From glucose and aminoacids dNTPs are generated for the 
duplication of nuclear and mitochondrial DNA. Many enzymes are 
involved in the production of the inosine monophosphate (IMP) 
and the uridine monophosphate (UMP), that are the precursors 
from which all the ribonucleoside 5'-diphosphates (NDP) derive. 
The ribonucleotide reductase (RNR) is a key enzyme of the de 
novo synthesis (Reichard, P., 1988; Nordlund, P., 2006). It 
catalyzes the reduction of NDP to 2'-deoxy-ribonucleosides 5'-
diphosphate (dNDP) (Fairman, J.W. et al., 2011) and leads directly 
to the production of dADP, dGDP, dCDP, dUDP that are further 
phosphorylated by specific kinases. 
RNR is finely regulated at trascriptional and post-trascriptional 
levels and by different subcellular localizations (Nordlund, P . and 
Reichard, P., 2006; Kolberg, M. et al., 2004). It exerts the 
maximum activity during S phase when the demand of dNTPs 
increases, supporting DNA replication. The active form of RNR is 
characterized by two copies of R1 subunit (88 kDa) and two copies 
of R2 (44 kDa) (Jordan, A. and Reichard, P., 1998). The catalytic 
site is assembled and activated when the two R2 subunits bind R1 
molecules (Nordlund, P., and Reichard, P. 2006). 
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R1 contains two allosteric sites, mediating regulation of substrate 
specificity and activity. The specificity site regulates the correct 
balance of four ribonucleotides through their direct binding. The 
activity site regulates dNTP pool levels according to dATP and 
ATP concentrations. ATP activates RNR, while dATP inhibits the 
enzyme (Brown, C.N., and Reichard, P. 1969). R2 is expressed 
specifically in the S phase and has very short half-life (about 3 
hours). In contrast, the levels of the subunit R1 are constant 
throughout the cell cycle, with a half-life of 20 hours (Eriksson, S. 
et al., 1984; Mann, G.J. et al., 1988). In cells that do not proliferate 
R1 can bind another subunit of RNR, the p53R2 (Tanaka, H. et al., 
2000; Nakano, K. et al., 2000). This subunit has a high sequence 
homology with the R2 (80%), depends on p53 activity and its 
expression is found during all phases of cell cycle. The p53R2 is 
important for the repair of DNA damage in proliferating cells, and 
also for mitochondrial DNA replication and nuclear DNA repair in 
post-mitotic cells. 
 
 
Figure 3.5 Allosteric regulation of RNR. RNR is activated by binding ATP or 
inactivated by binding dATP to the activity site located on the large subunit Rnr1 
(R1). When the enzyme is activated, substrates are reduced if the corresponding 
effectors bind to the allosteric substrate specificity site as follows. When dATP or 
ATP is bound at the allosteric site, the enzyme accepts UDP and CDP into the 
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catalytic site. When dGTP is bound, ADP enters the catalytic site. When dTTP is 
bound, GDP enters the catalytic site. The substrates (UDP, CDP, ADP, and GDP) 
are converted to dNTPs. Scientific Figure on ResearchGate. Available from: 
https://www.researchgate.net/figure/46577223_fig1_Figure-1-Ribonucleotide-
reductase-RNR-and-its-allosteric-regulation-A-The-enzyme  
 
Unlike dATP, dGTP and dCTP, the dTTP synthesis follows a 
different and more complex pathway. It starts from the reduction of 
UDP and CDP, getting numerous other enzymes involved, 
including the deoxycytidine deaminase, thymidylate synthase and 
thymidylate kinase. The resulting dTDP is then further 
phosphorylated to dTTP from its specific nucleoside diphosphate 
kinase (Carreras, C.W. and Santi, D.V., 1995). 
The salvage pathway is controlled by cytosolic and mitochondrial 
enzymes. dNTPs can be producted from DNA repair, mRNA 
degradation (Thelander L. and P. Reichard 1979). Otherwise, they 
can be derived from diet (Arner, E.S.J. and Eriksson, S. 1995) and 
hepatic metabolism (Fustin, J.M. et al., 2012). The cell can uptake 
deoxyribonucleosides (NdR) from the extracellular space through 
systems of cotransport with Na+ or by the membrane channels 
whose activity depends on the NdR concentration (Kong, W. et al., 
2004). NdR inside the cell are mono-phosphorylated by 
deoxyribonucleoside kinases (dNK), losing the ability to cross the 
plasma membrane. In mammalian cells there are four dNK, each 
one with a specific distinct substrate which ensures the 
monophosphorylation of all the nucleotide precursors (Arner ESJ 
and S. Eriksson 1995). Thymidine kinase (TK1) phosphorylates 
deoxythymidine and deoxyuridine while deoxycytidine kinase 
(dCK) catalyzes the phosphorylation of deoxycytidine, 
deoxyadenosine and deoxyguanosine. The thymidine kinase 2 
(TK2) differs from TK1 since it phosphorylates besides 
deoxyuridine and deoxythymidine also deoxycytidine. The 
deoxyguanosine kinase (dGK), instead, phosphorylates 
deoxyadenosine and deoxyguanosine (Eriksson, S. et al., 2002). 
TK1 and dCK have a cytosolic localization, while TK2 and dGK 
reside in the mitochondria. TK1 is active only during the S phase, 
while the other dNK are constitutively expressed and suffer slight 
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activity modulations during the cell cycle (Franzolin, E. et al., 
2006; Leanza et al., 2008). The Timidine kinase 1 is regulated at 
transcriptional (Kim, Y.K. and Lee, A.S., 1991; Stuart, P. et al., 
1985), post-trascriptional (Chang, Z. F., 1990; Lieberman H.B., 
1988) and translational levels (Chou, W.L. and Chang, Z.F. 2001; 
Sherley, J.L. and Kelly, T. J., 1988). It is degradated in G2/M 
transition by APC/C-Cdh complex. It is important to know that in 
post-mitotic cells the TK1 trascription is inhibited, reducing the 
activity of the enzyme (Wintersberger, E. et al., 1992) The 
deoxyribonucleoside monophosphates undergo also into two 
reversible phosphorylations by nucleoside monophosphate kinase 
(NMPK) and nucleoside diphosphate kinase (NDPK), which 
transform  deoxyribonucleoside monophosphates to diphosphates 
and then in triphosphates (Van Rompay, A. R. et al., 2000). 
The levels of dNTPs are kept under tight control by an efficient 
pathway of degradation. Both the absence and the excess of the 
four different dNTPs can determine mutagenesis and genomic 
instability (Mathews, C.K., 2006). Therefore, catabolic enzymes 
must eliminate the excess of deoxyribonucleotides triphosphates. 
5’deoxynucleotidases remove the phosphate in 5’ position 
trasforming dNMP in NdR. 5’deoxynucleotidases carry out an 
important regolative function since they are able to increase 
cellular metabolic sensibility (Newsholme, E.A. et al., 1984: 
Gazziola, C. et al., 2001). Other enzymes like phosphorylases, 
deaminases and hydrolyses are involved in the dNTP metabolism. 
Recently it was described the role of sterile alpha motif and HD-
domain containing protein (SAMHD1). SAMHD1 is a 
deoxyribonucleside triphospate hydrolyse, which activity is 
regulated by GTP binding. During G1 phase, this protein can 
dephosphorylate dNTPs, removing their excess. SAMHD1 
regulation is opposite respect to that of RNR. During S phase, in 
order to guaratee a right amount of nucleotides SAMHD1 is 
downregualted while RNR activity is very high. In G1 phase the 
levels of SAMHD1 are elevated while that of RNR are very low 
(Franzolin, E. et al., 2013). 
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3.4.  Xenopus Egg Extracts (XEE) 
 
Xenopus is a genus of African frogs native of sub-saharan Africa. 
The two best-known species of this genus are Xenopus laevis and 
Xenopus tropicalis, which are commonly studied as model 
organisms for neuroscience, developmental biology, toxicology, 
and cell biology. 
Unfertilized eggs from Xenopus laevis are used to product cell-free 
extracts, which are powerful tools to study, among other biological  
fields, cell cycle progression, chromatin structure and DNA 
replication. The first extracts were prepared by Lohka and Masui 
(Lohka, M., and Masui, Y. 1983) and were widely used after by 
Blow and Laskey, and Hutchison and colleagues, in the mid-80s.  
Depending on the scientific question to be investigated, several 
types of extracts can be obtained. Xenopus unfertilized eggs 
arrested in metaphase of meiosis II are collected and crushed by 
sequential centrifugations. Low speed extracts (LSE) are prepared 
by a medium-speed centrifigation and contain the cytoplasm 
including light membranes, ribosomes and nuclear envelope. LSE 
extracts can be interphasic, if unfertilized eggs, before crushing, 
are activated by calcium ionophore mimicking the fertilization, or 
mitotic, if the eggs remain unactivated without calcium addition. 
LSE interphasic extracts are used to study chromatin assembly, 
pre-replication complex formation and loading on chromatin, 
origin firing and DNA replication, nuclear assemble. LSE mitotic 
extracts are employed to analyze chromosome condensation and 
mitotic spindle formation.  
XEE can undergo an additional high speed centrifugation 
producing high speed extracts (HSE). This extra centrifugation 
separates the cytoplasm from membranes and ribosomes. 
In our laboratory LSE interphasic extracts are used to study DNA 
replication in terminally differentiated cells. In the absence of an 
intact cell, these extracts recapitulate the key nuclear transitions of 
the eukaryotic cell cycle in vitro under apparently the same 
controls that exist in vivo (Blow J.J. et al, 1988).  
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They are able to duplicate exogenous DNA molecules (Tutter A., 
2006) since they contain all the replication factors necessary to 
DNA synthesis. DNA added to the extracts is first assembled into 
chromatin and then into structures corresponding to interphase 
nuclei. Once nuclear assembly is complete, the DNA is efficiently 
replicated in a semi conservative way (fig 3.6) 
 
 
Figure 3.6 Nuclear assembly and DNA replication in Xenopus egg extracts. (A) 
Timecourse of nuclear formation in Xenopus egg extracts. Sperm nuclei incubated 
in metaphase arrested Xenopus egg extracts released into interphase by addition of 
CaCl2. (B) The replication kinetics of sperm nuclei added to interphase egg extracts. 
Figure from Gillespie, P.J. et al. 2012. 
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2.  AIMS 
 
Today, reactivating the cell cycle of TD cells is achievable. 
Although the reactivated cells can carry out mitosis and even 
cytokinesis, S phase represents a major hurdle, since DNA 
duplication is not completed, resulting in cell death. The ability to 
induce proliferation into terminally differentiated cells such as 
neurons, cardiomyocytes, or endocrine cells would have a major 
impact on the therapy of inherited and acquired diseases and 
damaged tissues. 
Skeletal muscle cells are a prototypic example of terminal 
differentiation, being extremely resistant to a wide variety of 
mitogenic stimuli. It is easy to culture them in large numbers. Their 
differentiation program, extensively studied, can be readily 
triggered in culture and normally requires cell cycle exit to be 
executed. For these reasons, they constitute an excellent model 
system to study terminal differentiation. Indeed, at least in some 
cases, it has been shown that methods to reactivate the cell cycle in 
myotubes attain the same result in other TD cells. 
Understanding the reasons behind the inability of myotubes to fully 
replicate their genomes is the objective of this thesis. Theoretically, 
two classes of problems might impair DNA replication: functional 
and structural obstacles. With “functional problems”, we indicate 
biochemical defects in the replication machinery; the expression 
“structural obstacles” refers to any unusual conformation of the 
genetic material that might physically prevents DNA replication.  
Since both a deficiency and a surplus of dNTPs can cause genomic 
instability, DNA damage, and mitotic catastrophe (Kunz, B. 1994), 
we explored the nucleotide pool in reactivated myotubes and its 
potential impact on DNA replication. 
To determine whether a structural obstacle to DNA replication 
does exist in myotubes, we chose to use cell-free extracts from 
Xenopus laevis unfertilized eggs. These extracts autonomously 
duplicate any type of genetic material, including purified DNA 
(Blow J.J et al 1988). We wished to study DNA replication in 
myotube nuclei incubated in XEE, in comparison with nuclei from 
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myoblasts. We reasoned that, since XEE provide the entire DNA 
replication machinery, incomplete DNA synthesis in Mt nuclei 
would imply the presence of a structural impediment. To begin to 
dissect the nature of such hypothetical obstacle, we subdivided the 
nucleus into different levels of complexity: naked DNA, DNA 
arranged into nucleosomes, and intact chromatin. Once purified, 
these distinct samples will be incubated in XEE to evaluate their 
replicability. The level at which the obstacle lays should then 
become clear. 
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4. RESULTS 
 
To study, at the functional level, the inability of myotubes to 
complete replication, we quantified dNTP pool in proliferating 
murine myoblasts and in myotubes, either resting or reactivated by 
RNA interference against p21 and p27 CKIs (Pajalunga et al., 
2007). We evaluated the percentage of cells double-positive for 5-
bromo-2'-deoxyuridine (BrdU) and myosin heavy chain (MHC) in 
the culture to measure reactivation efficiency (30/40%). rMt were 
analyzed at 28, 30 and 36 hours after cell cycle reactivation. 
Proliferating myoblasts exhibited a typical balance of the four 
dNTPs, while resting myotubes showed the expected low levels 
(Frangini et al., 2013) (Fig. 5.1).  
In rMt the amounts of deoxytimidine and deoxyguanosine 
triphosphate (dTTP and dGTP) remained very low, while, in 
contrast, the levels of deoxycytidine and deoxyadenosine 
triphosphate (dCTP and dATP) were markedly higher than the 
levels found in proliferating myoblasts (Fig. 5.1 and Table 1).  
 
Figure 5.1 Reactivated myotubes display low levels of dTTP and dGTP. Myotubes 
were transfected with siRNAs to p21 and p27 (Mt p21p27i) or to GFP as a control 
(Mt CTRi) and harvested at the indicated times from the beginning of treatment 
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(Hrs fbt). Reference samples include proliferating myoblasts (Prol Mb), myoblasts 
cultured in suspension to attain quiescence (Q), and formerly quiescent myoblasts 
reactivated by replating (rQ). The dNTP pool was extracted with 60% methanol and 
individual dNTPs quantitated by a DNA polymerase-based assay. Data are 
presented as averages ± SEM of the indicated numbers (n) of independent 
experiments 
Table 1. Statistical evaluation of dNTP measurements 
 
  p (Student’s t test)   
Samples dTTP dGTP dCTP dATP Comparison 
      
Mt p21p27i < 0.01 < 0.01 < 0.01 < 0.05 Prol Mb 
Mt p21p27i 28h <0,05 <0,05 <0,05 N.S. Prol Mb 
Mt p21p27i 30h <0,05 <0,05 <0,05 <0,05 Prol Mb 
Mt p21p27i 36h <0,05 <0,05 <0,05 <0,05 Prol Mb 
Mt p21p27i 
GdR+TdR 
< 0.01 < 0.01 N.S. N.S. Mt p21p27i 
Mt p21p27i GdR < 0.01 < 0.05 N.S. N.S. Mt p21p27i 
Mt p21p27i TdR < 0.05 < 0.05 N.S. N.S. Mt p21p27i 
Ad-TK 20h < 0.05 N.S < 0.05 < 0.05 Prol Mb 
Mt p21p27i  Ad-Ctr 
20h 
< 0.05 < 0.05 < 0.05 < 0.05 Prol Mb 
Mt p21p27i  Ad-TK 
20h 
< 0.05 < 0.05 N.S. < 0.05 Prol Mb 
Ad-TK 30h < 0.05 - < 0.05 < 0.05 Prol Mb 
Mt p21p27i  Ad-Ctr 
30h 
< 0.05 < 0.05 < 0.05 < 0.05 Prol Mb 
Mt p21p27i  Ad-TK 
30h 
< 0.05 < 0.05 < 0.05 < 0.05 Prol Mb 
Prol Mb: proliferating myoblasts; Mt p21p27i: myotubes reactivated by p21 and 
p27 RNAi; Mt p21p27i GdR, TdR, or GdR+TdR: myotubes reactivated in the 
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presence of 500 µM deoxyguanosine, 100 µM thymidine, or both; Ad-TK: resting 
myotubes infected by adenovirus carrying TK of herpes simplex virus; Mt p21p27i 
Ad-Ctr: myotubes reactivated by p21 and p27 RNAi and infected by control 
adenovirus; Mt p21p27i  Ad-TK 20h: myotubes reactivated by p21 and p27 RNAi 
and infected by adenovirus carrying TK of herpes simplex virus N.S.: not 
significant. 
 
To ascertain that quiescent, proliferation-competent cells promptly 
expand their nucleotide pool upon reentry into S phase, we 
performed the same analyses in myoblasts rendered quiescent in 
suspension culture (Milasincic et al., 1996). As expected, in a 
single experiment, the low amounts of the four dNTPs found in 
quiescence promptly rose to proliferation levels upon cell cycle 
reactivation by reestablishment of substrate adhesion (Fig 5.1). 
Since rMt cannot completely duplicate DNA, these data prompted 
us to ask whether restoring proliferation-like levels of dTTP and 
dGTP would extend DNA replication. 
Two general, opposite, and complementary ways to increase dNTP 
levels are blocking their catabolism or enhancing their 
biosynthesis.  
Initially we took the first approach by knocking down, with a short 
interfering RNA (siRNA), SAM domain and HD domain-
containing protein 1 (SAMHD1), a key nucleotide catabolic 
enzyme that coordinates the dNTP pool with the cell cycle 
(Franzolin et al., 2013). Western blotting indicated an efficient 
knockdown (Fig. 5.2). 
A preliminary experiment was performed to analyze dNTP pool in 
rMt interfered for SAMHD1. We observed an increase in the levels 
of dCTP at 30 and 36 hours after cell cycle reactivation. However, 
the dTTP and dGTP pools were not affected by this manipulation, 
suggesting that their shortage may be determined by deficient 
synthesis, rather than high catabolism (Fig. 5.3). Hence, this 
approach was not further pursued. 
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Figure 5.2 Down regulation of SAMHD1. Western blot showing  SAMHD1 (SAM) in 
myoblasts or myotubes under the indicated conditions. Myoblasts have been 
included as a reference for SAMHD1 levels in proliferating, quiescent, or 
reactivated conditions. 
 
 
Figure 5.3 Suppression of SAMHD1 does not increase dGTP or dTTP levels. dNTP 
levels in p21p27i: myotubes reactivated by p21 and p27 RNAi analyzed at 30 and 36 
hrs post transfection; p21p27 SAMi: myotubes reactivated by p21 and p27 RNAi 
and treated with RNAi against SAMHD1, analyzed at 30 and 36 hrs post 
transfection. 
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Thus, we adopted an alternative approach to remodel the dNTP 
pool. We supplemented the medium of rMt with 500 µM 
deoxyguanosine (GdR) and/or 100 µM deoxythymidine (TdR). 
The concentrations were chosen after pilot experiments to obtain 
dTTP and dGTP levels roughly similar to those found in 
proliferation. The administration time was critical. We observed 
that early treatment with nucleosides inhibited S phase entry in rMt 
and found that the optimal time for addition was 17 hours after 
CKI siRNA transfection, closer to the beginning of S phase 
(ranging from 20 to 28 hrs post-transfection). Figure 5.4 shows that 
exogenous addition of GdR+TdR increased both dGTP and dTTP. 
Moreover, we obtained that TdR alone was able to increase both 
deficient nucleotides. In contrast, the sole addition of GdR 
exclusively raised dGTP levels (Table 1).  
 
 
Figure 5.4 Supplementation of GdR or TdR. Myotubes were transfected with p21 
and p27 siRNAs as in Figure 5.1. GdR (500 µM) and/or TdR (100 µM) were added 
to the culture medium 17 hrs later. The dNTP pool was quantitated as in Fig. 5.1 30 
hrs fbt. Values for proliferating myoblasts and myotubes reactivated by p21 and p27 
RNAi are the same shown in Fig. 5.1 and are reproduced here for ease of reference. 
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To explore the connection between DNA replication and dNTP 
pool in rMt, we performed in situ microfluorimetric measurements 
of DNA content in individual nuclei, as reflected by 4',6-
diamidino-2-phenylindole dilactate (DAPI) fluorescence intensity. 
This analysis was made to quantify the extent of DNA replication 
in all of the above conditions.  
rMt with GdR+TdR increased significantly DNA synthesis (DNA 
content 52% above controls) (Fig. 5.5 and Table 2) 
 
  
Figure 5.5 Higher dTTP and dGTP levels allow extended DNA replication in 
reactivated myotubes. Myotubes were transfected as in Figure 5.4; at the end of S 
phase, 30 hrs later, the cells were immunostained for MCM7, a marker of cell cycle 
reactivation, and counterstained with DAPI. Nuclear DNA content was evaluated by 
microfluorimetric measurement of DAPI fluorescence in individual, MCM7+ 
myotube nuclei. On average, 209 nuclei per sample were evaluated (range 112-285) 
and their DNA-content distribution is shown by the corresponding curve. Control 
TD myotube nuclei were uniformly MCM7- and their DNA content was determined 
without selection. 
 
To investigate the distinct contribution of each of the two 
deoxynucleosides, we treated rMt with either GdR or TdR. 
Administration of GdR, in agreement with its incapacity to 
increase dTTP levels, was not able to increase rMt DNA synthesis 
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in a significant way. In contrast, treatment with TdR alone, which 
raised both dTTP and dGTP levels, increased rMt DNA content to 
56% above control myotubes, mimicking the combined action of 
GdR+TdR (Fig. 5.6 and Table 2). These data show how the DNA 
replication in rMt is influenced by the intracellular levels of TdR. 
Indeed, administration of deoxythymidine alone is sufficient to 
double the amount of the duplicated DNA. 
 
 
Figure 5.6 TdR alone is sufficient to extend DNA replication. Myotubes were 
transfected as in Figure 5.4; at the end of S phase, 30 hrs later, the cells were 
immunostained for MCM7, a marker of cell cycle reactivation, and counterstained 
with DAPI. Nuclear DNA content was evaluated by microfluorimetric measurement 
of DAPI fluorescence in individual, MCM7+ myotube nuclei. On average, 209 nuclei 
per sample were evaluated (range 112-285) and their DNA-content distribution is 
shown by the corresponding curve. Control TD myotube nuclei were uniformly 
MCM7- and their DNA content was determined without selection. 
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Table 2. DNA content in myotube nuclei and statistical analyses 
 
Samples DNA content 
(% increase 
above 2n) 
S.D. n p (Student’s 
t test) 
Comparison 
      
CTRi 0  4   
CTRi GdR 3 0.7 2 N.S. CTRi 
CTRi TdR 1 2.1 2 N.S. CTRi 
p21p27i 27 2.5 4 <0.05 CTRi 
p21p27i 
GdR+TdR 
52 11.0 20 <0.05 CTRi 
p21p27i 
GdR 
29 3.4 2 <0.05 CTRi 
p21p27i 
TdR 
56 6.5 2 <0.05 CTRi 
 
CTRi, CTRi GdR, CTRi TdR Myotubes transfected with siRNAs to GFP as a 
control and where mentioned, with 500 µM deoxyguanosine or 100 µM thymidine; 
Mt p21p27i: myotubes reactivated by p21 and p27 RNAi; Mt p21p27i GdR, TdR, or 
GdR+TdR: myotubes reactivated in the presence of 500 µM deoxyguanosine, 100 
µM thymidine, or both; Data are presented as averages ± SEM of 2-4 experiments. 
N.S. non significant, S.D. standard deviation. 
 
Since reactivation of cell cycle in terminally differentiated cells 
induce also DNA damage (Pajalunga et al., 2010), we investigated 
whether administration of exogenous deoxynucleosides could able 
to reduce genomic lesions. To this aim, we performed 
microfluorimetry for γ-H2AX, a marker of double-strand DNA 
breaks, on rMt with or without addition of GdR+TdR. 
Deoxynucleoside supplementation caused a significant reduction in 
γ-H2AX staining (Fig. 5.7 and Fig. 5.8). This result indicates that 
at least part of the damage incurred by myotubes in the course of 
cell cycle reactivation is due to insufficient availability of 
deoxynucleotides. 
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Figura 5.7 Myotubes, treated as indicated, were subjected 30 hrs fbt to 
immunofluorescence for Ki67, a marker of cell cycle reactivation, and γ-H2AX 
staining. Intensities of individual Ki67+ nuclei were measured by microfluorimetry. 
Control myotubes displayed no detectable γ-H2AX fluorescence and are not 
reported in the graph. It is shown an average of 2 independent experiments S.D. 
4,70. Myotubes p21p27i GdR+TdR have the 40% of DNA damage reduction. 
 
To understand the reason of the relative lack of some nucleotides 
in rMt, we analyzed by quantitative, real-time PCR (qPCR) the 
expression pattern of a number of enzymes involved in their 
biosynthesis. Figure 5.9 shows that, as expected of non-
proliferating cells, resting myotubes replace the ribonucleotide 
reductase R2 subunit with p53R2 (Hakansson et al., 2006). At least 
three enzymes involved in deoxythimidine synthesis (dCMP 
deaminase, DCTD; thymidilate synthase, TS; thymidine kinase 1, 
TK1) were strongly dowregulated in these myotubes (Table 3). 
Their expression barely rose upon cell cycle reentry, suggesting an 
explanation for the very low levels of dTTP found in rMt. 
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Figure 5.8 Immunofluorescence for γ-H2AX. p21p27i reactivated myotubes were 
subjected 30 hrs fbt to immunofluorescence for γ-H2AX and BrdU staining with or 
without TdR+GdR. 
 
As a control, we performed the same analyses in quiescent 
myoblasts. They displayed a slight downregulation of the 
thymidine synthesis enzymes and, upon cell cycle reactivation, 
promptly returned to an expression pattern similar to that of 
proliferating cells (Fig. 5.10 and Table 3). 
 
Figura 5.9 Thymidine synthetic enzymes are not upregulated in reactivated 
myotubes. Myotubes were reactivated by CKI depletion. The mRNA levels of 
several dNTP synthetic enzymes were quantitated by qPCR in myotubes treated as 
indicated, proliferating myoblasts, and quiescent myoblasts or myoblasts 
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reactivated after quiescence. In all cases, reactivated cells were harvested in the mid 
of S phase. Histograms show fold increases in comparison with proliferating 
myoblasts, made equal to 1 (averages ± SEM of two independent experiments). R1, 
R2, and p53R2 indicate the corresponding ribonucleotide reductase subunits; 
DCTD, deoxycytidine monophosphate deaminase; TS, thymidilate synthase; TK1 
and TK2, thymidine kinases 1 and 2; dGK, deoxyguanosine kinase. 
 
Figura 5.10 Biosynthetic enzymes are upregulated in reactivated quiescent 
myoblasts. The mRNA levels of several dNTP synthetic enzymes were quantitated 
by qPCR in proliferating myoblasts, and quiescent myoblasts or myoblasts 
reactivated after quiescence. Reactivated quiescent cells were harvested in the mid 
of S phase. Histograms show fold increases in comparison with proliferating 
myoblasts, made equal to 1 (averages ± SEM of two independent experiments). 
 
Table 3. Statistical evaluation of gene expression in reactivated myotubes or 
myoblasts, compared to proliferating myoblasts. 
p (Student’s t test) 
Samples R1 R2 P53R2 dCTD TS TK TK2 DGK 
Mt 
p21p27i 
N.S. <0,05 N.S. <0,05 <0,05 <0,05 N.S. N.S. 
Qr N.S. N.S. N.S. N.S. N.S. N.S. N.S. <0.05 
Mt p21p27i: myotubes reactivated by p21 and p27 RNAi; N.S.: not significant. 
 
Altogether, these results indicate that low expression of enzymes 
converging on dTTP biosynthesis are responsible for the limiting 
amount of this nucleotide in rMt. 
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We focused our attention on TK1. Indeed this enzyme is encoded 
by a highly cell cycle-dependent gene, whose transcription is 
strongly downregulated in non-proliferating cells and sharply 
increases at the G1/S boundary, upon cell cycle reentry. We asked 
if TK1, upon cell cycle reactivation, could execute its function in 
rMt. We used a kinase assay to measure TK1 activity. We found 
that in rMt it only moderately increased, compared with resting 
myotubes, and never reached the TK1 levels found in proliferating 
myoblasts (Fig. 5.11). 
  
Figure 5.11 TK activity is low in reactivated myotubes. Total TK activity in 
myoblast or myotubes, treated as indicated and collected 30 hrs fbt. In vitro kinase 
assays were performed on total proteins extracted from the different samples, using 
3HTdR as substrate. The reactions were incubated at 37°C and a specific inhibitor of 
TK2 activity (KIN109) was used, in order to quantify only the amount of 3HTMP 
produced by TK1. Prol Mb: proliferating myoblasts; Mt p21p27i: myotubes 
reactivated by p21 and p27 RNAi; Mt p21p27i GdR, TdR, or GdR+TdR: myotubes 
reactivated in the presence of 500 µM deoxyguanosine, 100 µM thymidine, or both; 
Ad-TK: resting myotubes infected by adenovirus carrying TK of herpes simplex 
virus; Mt p21p27i Ad-Ctr: myotubes reactivated by p21 and p27 RNAi ad infected 
by control Adenovirus; Mt p21p27i  Ad-TK: myotubes reactivated by p21 and p27 
RNAi and infected by adenovirus carrying TK of herpes simplex virus. The scale is 
logarithmic to accommodate widely different values. TK activities measured in 
myotubes are all statistically significant, in comparison with myoblasts (p < 0.05 by 
Student’s t test). 
Thus, we attempted to overexpress thymidine kinase 1. To this 
aim, rMt were infected with a recombinant adenovirus carrying 
herpes simplex thymidine kinase (Ad-TK) or a control virus. Ad-
TK muscle cells exhibited extremely high levels of dTTP, 
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irrespective of cell cycle reentry. Interestingly, they also showed a 
marked increase in dGTP (Fig 5.12, Table 1). As expected, 
control-infected rMt displayed limited DNA replication. In 
contrast, in rMt forcibly expressing TK, DNA synthesis was 
dramatically extended, though not reaching completion (Fig. 5.13 
and Table 4).  
 
 
Figure 5.12 TK1 overexpression increase both dTTP and dGTP. dNTP pools 
measured at the indicated times in myoblasts or myotubes treated as shown. 
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Figure 5.13 Exogenous thymidine kinase 1 expression extends DNA synthesis in 
reactivated myotubes. Microfluorimetric measurements of DNA contents in the 
indicated cell samples, harvested 30 hrs fbt. CTRi, interference with control siRNA; 
Ad-CTR, infection with control adenovirus; Ad-TK, infection with the adenovirus 
expressing herpes simplex virus TK. 
 
Table 4.  DNA content in reactivated myotubes, as pecentage increase above 
controls and statistical measurements 
 
 
Samples 
DNA content 
(% increase 
above 2n) 
S.D. n p (Kolmogorov-
Smirnov Test) 
Comparison 
      
CTRi 0 0 2   
CTRi Ad-CTR 2 2.8 2  N.S. CTRi 
CTRi Ad-TK 0 0 2  N.S. CTRi 
p21p27i Ad-
CTR 
24 9.9 2 < 0.000001 CTRi 
p21p27i Ad-TK 56 4.9 2 < 0.000001 CTRi 
 N.S. not significant 
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We sought to confirm the role of TK1 in dNTP pool synthesis and 
DNA replication in rMt. For this purpose, rMt underwent TK1 
RNAi. To demonstrate the efficacy of the knockdown, in the 
absence of suitable antibodies against the murine enzyme, we 
resorted to a functional assay. Figure 5.14 shows that EdU 
incorporation into rMt largely depends on TK1 expression, as low 
as it might be in these cells. Myotubes were similarly reactivated  
by CKI suppression, independently of TK1 interference, as shown 
by the expression of the cell cycle-dependent protein MCM7. 
However, in TK1-knockdown cells, EdU was nearly undetectable. 
TK1 knockdown markedly reduced DNA replication in myotubes 
reactivated by CKI RNAi (Fig. 5.15), confirming the crucial role of 
this enzyme in limiting DNA synthesis. Altogether, these results 
show that inadequate expression of enzymes involved in dTTP 
anabolism is responsible for low dNTP levels and confirms that 
expanding the dNTP pool results in enhanced DNA synthesis. 
 
Figure 5.14 TK1 suppression impairs EdU incorporation. Double 
immunofluorescence for MCM7 and EdU in p21p27-depleted myotubes, 
additionally subjected to interference with TK1 or control siRNA. Cultures were 
fixed during S phase and stained as indicated. FC, phase contrast. 
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Figure 5.15 Suppression of TK1 impairs DNA replication in reactivated myotubes. 
Microfluorimetric measurements of DNA contents in the indicated cell samples, 
assayed 31 hrs fbt.  
To investigate whether structural obstacles prevent myotubes from 
completing DNA duplication, we used Xenopus egg extracts (XEE) 
to drive in vitro replication assays. These extracts contain all the 
factors necessary to replicate DNA in any form (Tutter AV, et al 
2006). We reasoned that any biochemical defects underlying 
incomplete DNA replication in myotubes would be ignored by the 
self-sufficient XEE replication machinery. In contrast, incomplete 
DNA replication in these conditions would constitute a strong 
indication of the presence of structural impediment(s). 
Thus, we compared the replication kinetics of myotube and 
myoblast nuclei in XEE. Nuclei, isolated from proliferating (P) and 
quiescent (Q) myoblasts or myotubes, were incubated in XEE to 
quantify the amount of DNA synthesized during a period of 5 
hours. Q nuclei represent the most appropriate control, since they 
come from a synchronous population lying in G0 phase, like 
skeletal muscle TD cells. P nuclei were also included as a 
reference. However, a fraction of them have already gone through 
S phase in vivo and cannot re-replicate their DNA; thus, P nuclei, 
proliferating myoblasts 
myotubes 
quiescent myoblasts 
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on average, cannot attain 100% replication. Myotube nuclei started 
DNA replication more than 60 minutes later than Q ones. 
Furthermore, while Q nuclei essentially completed DNA 
replication within five hours, myotube DNA synthesis remained 
conspicuously incomplete (Fig. 5.16). 
 
 
 
Figura 5.16 Myotube nuclei do not completely replicate their DNA in XEE. 
Quantification of replicated DNA (per nucleus) in nuclei isolated from myotubes 
and quiescent or proliferating myoblasts. Nuclei were incubated in XEE in the 
presence of dTTP3H to follow replication kinetics. Aliquots were collected at the 
indicated time points. The amount of radioactivity per sample is a measure of the 
replicated DNA. In parallel, the same analyses were performed with a fluorescent 
tracer (Cy3-dCTP), to visualize the percentage of nuclei replicating their DNA 
(typical range, 70-90%). Radioactive measurements were normalized to the number 
of Cy3-dCTP+ nuclei and were plotted as percent of maximal DNA synthesis. Values 
are shown as means of three independent experiments with SE (error bars). At all 
time points, the differences between myotube and quiescent cell nuclei were 
statistically significant (p < 0.05 by Student’s t test). 
 
These data indicate that the inability of myotubes to complete 
DNA replication is due, in part, to the presence of structural 
obstacles. 
To begin to identify the molecular nature of such obstacle, we 
conceptually subdivided the nucleus into different levels of 
complexity: naked DNA, DNA arranged into nucleosomes, and 
intact chromatin. To determine at which of these levels of 
complexity the obstacle lies, we thought to study the replication 
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kinetics in XEE of different preparations of genetic material from 
myotubes and myoblasts (Fig 5.17). 
 
 
Figure 5.17 Schematic illustration of different levels of complexity taken into 
account to study the structural obstacle. 
 
By incubating DNA from myoblasts and myotubes in XEE, we 
observed that the amount of DNA synthesized by the two samples 
was similar (Fig. 5.18 and Table 6). This means that, at the level of 
purified DNA, there is no barrier prohibiting full DNA replication. 
At the next complexity level, nuclei were purified and treated with 
1M NaCl. High salt concentrations detach proteins not tightly 
bound to DNA.  
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Figure 5.18 Myotube nacked DNA replicate as much as proliferating samples in 
XEE.  Densitometry of replicated DNA from myotubes and proliferating myoblasts. 
Nacked DNA was incubated in XEE in the presence of biotinylated-dUTP to follow 
replication kinetics. Aliquots were collected at the indicated time points. Dot blot, 
incubation with streptavidin-peroxidase and chemiluminescent analyses were 
performed. Mt: myotubes DNA; Prol mb: myoblasts DNA. Values are shown as 
means of three independent experiments with ESs (error bars). At all time points, 
the differences between myotube and proliferating DNA were not statistically 
significant (p >0.05 by Student’s t test). 
 
To probe the results of such selective detachment, we performed an 
immunofluorescence against H1, the histone most weakly bound to 
DNA, and against pRB, one of the non-histone proteins most 
strongly attached to DNA (Fig 5.19). The presence of H1 and the 
absence of pRb confirmed a successful preparation. This 
conclusion has anyway to be proved by Western blot analyses.  
Preliminary results were obtained by studying the replication 
kinetics in XEE of salt-treated nuclei, using a fluorescent 
nucleotide (Cy3-dCTP) as a tracer. The percentages of dye-positive 
nuclei was calculated. 
NaCl-treated nuclei from proliferating cells and myotubes 
displayed similar percentages of labeled-dCTP incorporation (Fig 
5.20). 
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These results are going to be complemented by quantitative 
assessments of DNA replication.  
 
 
Figure 5.19 High salts treatment detaches pRB protein from DNA maintaining H1 
bound to chromatin. Immunofluorescence for pRb (green) and H1 (red) proteins. 
 
 
 
 
Figure 5.20 Salt treated nuclei from myotubes and proliferating cells show the same 
replication kinetic in XEE. Nuclei were extracted from the above mentioned cells. 
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They were treated with 1M NaCl and then incubated in XEE with Cy3-dCTP to 
follow the reaction. Aliquots were collected at indicated time points. Cy3-dCTP+ 
nuclei were counted and plotted. Untreated nuclei from myoblasts and myotubes 
were used as controls. Prol mb: myoblast nuclei; Mt: myotube nuclei; Prol mb+1M 
NaCl: myoblast nuclei treated with 1M NaCl; Mt+1M Nacl: myotube nuclei treated 
with 1M NaCl. 
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5. DISCUSSION 
 
TD cells can be forced to re-enter the cell cycle by several means, 
but they never attain proliferation, due to incomplete DNA 
replication associated with DNA damage. We regard the 
incompetence to fully replicate DNA as the last hurdle to 
overcome to finally achieve the goal of TD cell proliferation.  
The aim of this thesis was to understand the reason behind 
defective DNA duplication, distinguishing between functional and 
structural problems. I presented evidences that both classes of 
causes affect cell cycle reactivation in myotubes. 
We found that reactivated myotubes attempt to replicate their DNA 
with an aberrant dNTP pool (Fig 5.1). dTTP and dGTP amounts 
turn out to be very low, while dATP and dCTP reach very high 
levels, in comparison to those found in proliferating myoblasts. In 
reactivated myotubes, exogenous administration of GdR and TdR 
determines an increase in the levels of the corresponding dNTPs, 
resulting in the extension of the DNA replication (Fig. 5.4 and Fig 
5.6). Improving DNA synthesis lowers DNA damage (Fig. 5.7), as 
indicated by a decrease in H2AX phosphorylation.  
The contributions of TdR and GdR are not equal, since when cells 
are incubated with TdR, the concentrations of dGTP and dTTP rise 
in concert, enhancing DNA replication. In contrast, increasing 
dGTP alone is ineffective. These results can be explained by the 
role of dTTP which, through RNR, induces GDP reduction. 
The structure of the enzyme network regulating dNTP 
concentrations is altered. Insufficient expression of genes encoding 
key dTMP synthetic enzymes, prominent among which TK1, 
drastically hampers the production of dTTP (Fig. 5.9). Thus, the 
pathway converting dCMP to dTMP is virtually inactive in 
myotubes. Such inactivity causes accumulation of dCTP and lack 
of dTTP, which is not available for its twofold function as DNA 
precursor and allosteric stimulator of GDP reduction. Even though 
we did not measure RNR activity, we can suppose that such 
enzyme is active in reactivated myotubes. Indeed, cell-cycle 
reactivation restores both the transcription (Fig. 5.9) and the 
Sara Zribi 
 
Pag 56  
translation (data not shown) of RNR subunits in myotubes. 
Furthermore, p21p27i cells treated with HU, a specific inhibitor of 
RNR, show a great reduction in BrdU-positive myotubes (35% 
reduction) (data not shown).  
The role of TK1, whose activity is not restored upon cell cycle 
reactivation (Fig 5.11), is confirmed by its dowregulation, which 
further reduces the extent of DNA replication (Fig. 5.15).  
Conversely, reactivated myotubes expressing exogenous TK1 
display significantly extended DNA synthesis (Fig. 5.13).  
The relevance of dTTP in TD cells is validated by E1A-mediated 
cell cycle reactivation in myotubes. In fact, E1A expressing 
myotubes show increased levels of dTTP biosynthetic enzymes, 
enlarged dTTP pool, and accordingly, they extend DNA replication 
to 25% more than p21p27i myotubes (data not shown). Such 
results confirm the fundamental role of dTTP in the extension of 
DNA replication in reactivated TD cells. It is worth noting that 
herpes simplex virus type I, whose natural host is the neuron, 
carries its own ribonucleotide reductase and TK-encoding genes 
(Roizman 2001). This suggests that persistent TK silencing is a 
feature that characterizes other TD cell types, besides myotubes. 
To generalize the data presented in this thesis, we propose to study 
dTTP significance in other TD cells, such as keratinocytes. 
Despite the restoration of the dNTP pool to levels quite similar to 
those of proliferating cells, myotubes remain unable to fully 
duplicate their DNA. The XEE experiments provide a conceptual 
explanation. Myotube nuclei replicate only half of their genetic 
material, despite being incubated in the presence of all components 
necessary for DNA synthesis (Fig. 5.16). This indicates that a 
structural obstacle hinders DNA replication in myotubes. We 
presume that such obstacle does not take place in specific genomic 
loci, but it occurs randomly. Indeed, preliminary genomic 
hybridization studies suggest that reactivated myotube nuclei fail 
to duplicate their own DNA with a stochastic pattern, namely, no 
preferential hyporeplicated loci are found (data not shown).  
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Further XEE experiments reveal that the barrier is not present in 
naked DNA. Indeed, DNA purified from myotubes is replicated to 
the same extent as that from proliferating cells (Fig. 5.18). 
Once defined the nuclear complexity level on which the replication 
block lays, we will analyze the corresponding material by mass 
spectrometry. This approach will help us highlight the differences 
in chromatin protein constituents between proliferating cells and 
myotubes. These differences can be acted upon in order to achieve 
completion of DNA replication in TD cells. 
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7. MATERIALS AND METHODS 
 
7.1. CELL CULTURE 
 
Muscle satellite cells (MSC) were isolated as described by Rando 
T.A. in 1994. The MSC were grown on gelatin-coated dishes in 
growth medium (GM): Ham’s F-10 medium (Life Technologies) 
supplemented with 20% fetal bovine serum (FBS), 3% chicken 
embryo extract, and 2.5 ng/ml basic-FGF, antibiotics (10,000 
units/ml of Penicillin and 10,000 g/ml of streptomycin, GIBCO). 
Differentiation was induced by plating cells on gelatin-coated 
dishes in differentiation medium (DM): Dulbecco’s Modified 
Eagle Medium (Life Technologies) supplemented with 10% FBS 
and antibiotics. After 48 hours, the vast majority of the cells was 
differentiated (differentiation index higher than 95%). 
MSC were made quiescent by culturing them in suspension on 
semisolid medium (GM with 0.7% Noble Agar (Life 
Technologies) for 22 hrs. Cell cycle reentry was triggered by 
replating them on gelatin-coated dishes in liquid GM. 
The plates were kept at room temperature (38°C) and at 6.7% of 
CO2. The differentiated cells were detached from the culture plate 
by treatment with 1X trypsin (Gibco) for 2 minutes at 37°C. To 
mark the newly synthesized DNA, proliferating myoblasts and 
reactivated myotubes were cultured in the presence of 20 nM 5-
bromo-2'-deoxyuridine (BrdU). 
 
7.2.  RNA INTERFERENCE. 
 
Myotubes were transfected with the HiPerFect transfection reagent 
(QIAGEN) combined with siRNA. siGenome duplex (Dharmacon) 
siRNAs were used to interfere with murine CDKN1A (p21) and 
CDKN1B (p27) transcripts. The antisense sequences for p21 and 
p27 were 5’-P.GAACAGGUCGGACAUCACCUU-3’ and 5’-
P.UAUCCCGGCAGUGCUUCUCUU-3’, respectively. The 
antisense sequence to mouse SAMHD1 was 5’-
AUAGAAGUGAACACGAUCGAT-3’ (Qiagen). Interference 
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with murine TK1 and DCTD was carried out using Dharmacon 
siGenome SMART pools M-042809-00 and M-058063-02, 
respectively. The siRNA to GFP (antisense sequence: 5’-
GGUGCGCUCCUGGACGUAGCCUU-3’, Sigma Aldrich) was 
transfected as a control. Transfection complexes were kept in the 
culture medium throughout the experiment. 
 
7.3. DEOXYNUCLEOSIDE COMPLEMENTATION 
 
GdR and TdR (Sigma Aldrich) were added, singularly or in 
combination, to rMt culture medium at final concentrations of 500 
and 100 µM, respectively, 17 hr after siRNA transfection. GdR and 
TdR concentrations were chosen on empirical bases, taking into 
account the instability of GdR and the potential cell cycle-blocking 
effects of high levels of TdR. 
 
7.4. dNTP POOL ANALYSIS 
 
This procedure is carried out in collaboration with Dr. Chiara 
Rampazzo, from the University of Padua. dNTP pools were 
extracted from cell cultures with 60% ice-cold methanol for 1 hr. 
Cells left on the plate were dissolved in 0.3M NaOH and the 
A260nm of the lysates was used as an index of cell mass (Rando 
TA, et al., 1994). dNTP pool quantitations were performed by an in 
vitro modified DNA polymerase-based assay, as described (Ferraro 
P, et al., 2005). Two different aliquots of each pool extract were 
analyzed and pool sizes were normalized by the A260nm of the 
NaOH lysates (Frangini M, at al., 2013). 
 
7.5. IMMUNOFLUORESCENCE AND WESTERN 
BLOTTING 
 
Immunofluorescence was performed on cells (or on nuclei) fixed 
with 4% formaldehyde and permeabilized with 0.25% Triton X-
100 (Sigma Aldrich). For BrdU staining, DNA was denatured with 
2M hydrochloric acid. Primary mouse monoclonal antibodies were 
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used to detect: BrdU (Bu20a clone, DAKO); MCM7 (DCS-141 
clone, Santa Cruz); myosin heavy chain [MF20, (Bader et al., 
1982)]; γ-H2AX (JBW301 clone, Millipore); pRB (Pharmigen); 
H1 (S.Cruz) . Ki67 was detected with a rabbit policlonal antibody 
(Abcam). The modified thymidine analogue EdU, incorporated 
into newly synthesized DNA, was revealed by Click-iT Imaging 
kit (ThermoFisher Scientific). AlexaFluor 488- or 594-conjugated 
secondary antisera to mouse or rabbit IgG (Life Technologies) 
were used. Nuclei were counterstained with 0.2 µg/ml DAPI for 20 
min. 
To prepare total cell extracts, cells were harvested, washed in PBS, 
and lysed with RIPA buffer, containing 500mM NaCl. Proteins 
were separated on gradient, 4–12% polyacrylamide gels and 
analyzed by western blotting with the following antibodies: anti-
SAMHD1, anti-Cyclin A2 (C-19, Santa Cruz), anti-Pax7 
(Developmental Studies Hybridoma Bank cat. no. pax7, 
RRID:AB_528428), anti-Myogenin (FD5 hybrodoma), anti-β-
tubulin (2-28-33 clone, Sigma Aldrich). 
 
7.6. DNA QUANTITATION AND γ-H2AX EXPRESSION 
 
Microfluorimetry was used to quantitate DNA in myotube nuclei 
stained with DAPI, as multinucleated myotubes are not readily 
amenable to cytofluorimetry. rMt were allowed to synthesize DNA 
until shortly before M phase or cell death. The cells were then 
fixed, immunostained for MCM7 (a cell cycle-dipendent marker of 
reactivation), and counterstained with DAPI (Diffley, 2011). To 
assess the extent of DNA replication in rMt and exclude non-
reactivated ones, DAPI fluorescence intensity was measured solely 
in MCM7-positive nuclei. Control myotubes were subjected to the 
same treatments, but DAPI microfluorimetry was performed on all 
nuclei, which were uniformly MCM7-negative. Random myotube 
images were captured at room temperature, using an Axioskop 2 
Plus fluorescence microscope (Carl Zeiss) equipped with a 
Neofluar 40X objective (NA 0.75), and an AxioCam camera (Carl 
Zeiss). Images were capured with the ZEN 2012 software (Carl 
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Zeiss). The images were analyzed with the public domain software 
ImageJ (v. 1.43u). DAPI fluorescence intensity (proportional to 
DNA content) was measured in all well-defined individual nuclei 
in the captured images, with local background subtraction. 
Fluorescence values, in arbitrary units, were distributed into 20, 
equally-wide intensity channels and the percentages of total nuclei 
falling into each channel were plotted. The curves thus obtained 
were integrated to calculate the average fluorescence intensity 
(AFI) of the sample. In each experiment, the AFI of control 
myotube nuclei was made equal to 100% and the percent increase 
in DNA content in rMt nuclei was calculated. γ-H2AX levels were 
similarly measured, except that reactivated nuclei were detected by 
Ki67 immunofluorescence.  
 
7.7. GENE EXPRESSION ANALYSIS BY QUANTITATIVE 
REAL-TIME PCR 
 
Total RNA was isolated from cell cultures with TRIzol reagent 
(Thermo Fisher Scientific) and cDNA was synthesized from 2 µg 
of RNA using the High Capaciy cDNA Reverse Transcriptiion Kit 
(Applied Biosystem), according to the manufacturer's instructions. 
qPCR was performed with 0.3µl of cDNA (from a 20-µl total 
reaction volume), using SYBR Green cyanine dye (SensiMix, 
Bioline), on a 7500 Fast Real-Time PCR System (Applied 
Biosystems). The specificity of qPCR reactions was verified by the 
melting-temperature method. Each gene was assayed in triplicate 
and the mean threshold cycle (Ct) value was calculated. The Pctk1 
housekeeping gene (hg), found to be homogeneusly expressed in 
all samples, was used to normalize target gene (tg) results. 
Proliferating myoblasts were used as reference (Ctref). Gene 
expression fold-change was calculated as 2-ΔΔCt, where ΔΔCt = 
(Cttg - Cthg) - (Ctref - Cthg), setting to 1 the expression of tg in 
proliferating myoblasts.  
The following primers were used:  
RNR-R1 (5’-CCCAATGAGTGTCCTGGTCT-3’, 5’-
GTTCTGCTGGTTGCTCTTCC-3’);  
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RNR-R2 (5’-CCTACTAACCCCAGCGTTGA-3’, 5’-
GTTTCAGAGCTTCCCAGTGC-3’);  
RNR-p53R2 (5’-ACACACGCACACACCACCTGTA-3’, 5’-
TGACAAATGGGAAGCACAGAGC-3’);  
DCTD (5’-GAAGCAAGGACCCAAGTTTCC-3’, 5’-
CCTTCACATCAGCCGAGTTCT-3’);  
TS (5’-ATGTGGTGAATGGGGAACTGT-3’, 5’-
GAGCTTTGGGAAAGGTCTTGG-3’);  
TK1 (5’-CGATGTGACCCAGGAGTCC-3’, 5’-
GGAGAGTGTGGTGAAGCTCA-3’);  
TK2 (5’-TGTCCTTGTGTGAGAGAGCAGT-3’, 5’-
CTCCAGGGTATACGGTCATCAT-3’); 
 dGK (QuantiTect primer assay, Qiagen). 
 
7.8. THYMIDINE KINASE ENZYMATIC ASSAY 
 
Cultures of exponentially growing myoblasts and myotubes were 
rinsed three times with ice-cold 0.9% NaCl, drained, and collected 
by scraping in ice-cold lysis buffer (10 mM Tri-HCl, pH 7.5, 0.5% 
Triton X-100, 2 mM EDTA, 1 mM DTT), supplemented with 0.2 
M NaCl and protease inhibitors. Lysates were then centrifuged 
(16,000 g at 4°C for 30 min) and the supernatant was aliquoted and 
stored at -80°C. Protein concentration was determined by the 
Bradford colorimetric assay. TK activity was assayed as described 
by Franzolin E, et al., 2006. The substrate was 1 µM [3H]TdR 
(Perkin-Elmer Life Sciences) (800 cpm/ pmol) and two different 
aliquots of extracts were used to check for proportionality of the 
assay. We expressed TK activity as pmol product min-1 mg-1 
protein.   
 
7.9. PREPARATION OF XENOPUS LAEVIS INTERPHASE 
EGG EXTRACTS (XEE) 
 
XEE were provided in the context of a collaboration with 
Dr.Vincenzo Costanzo.  
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Female frogs were injected with 300U and 600U of Human 
Chorionic Gonadotropin respectively 24h and 16h before eggs 
collection and let in a 0.1M NaCl bath. After collection eggs 
were dejellied by several washes with the Dejellying Buffer 
(20mM Tris-HCl pH 8.5, 110 mM NaCl, 5 mM DTT) and then 
rinsed 3 times with MMR buffer (5 mM Hepes-NaOH pH7.5, 
100 mM NaCl, 0.5 mM KCl, 0.25 mM MgSO4, 0.5 mM CaCl2, 
25 μM EDTA). Dejellied eggs were then incubated with 2 µl of 
10 mM Calcium ionophore A23187 (Sigma). After 5-
10 minutes eggs were washed three times with MMR buffer and 
then rinsed twice with ice-cold S buffer (50 mM Hepes-NaOH pH 
7.5, 50 mM KCl, 2.5 mM MgCl2, 250 mM sucrose) freshly 
supplemented with 2 mM β-mercaptoethanol and 
15 μg/ml Leupeptin. Activated eggs were packed by centrifugation 
(few seconds at 3300 x g in a microcentrifuge) to get rid of excess 
buffer and then crushed by centrifugation for 10 minutes at 16100 
g. Crude extract was separated from yolk and insoluble material, 
supplemented with 40µg/ml of Cytochalasin B and 
then ultracentrifuged for 18 min at 70000 rpm at 4°C with a 
TLA100 rotor (Beckman). The final extract, obtained by mixing 
the clarified protein extract and the membranes fraction was 
supplemented with 200 μg/ml Cycloheximide (Calbiochem). 
 
7.10.  NUCLEI PREPARATION 
 
Cells were collected and centrifugated to obtain a pellet. The pellet 
was resuspended with IPO Buffer (10 mM K-Hepes (pH 7.5), 2 
mM KCl, 2mM MgCl2,1 mM DDT, 1 mM PMSF, 1 mM protease 
inhibitors)). Samples were incubated for 60 min on ice and then 
centrifuged at 250 g for 4 min at + 4°C. To eliminate cellular 
debris, cells were incubated at room temperature (2 min for 
myoblasts and 4 min for myotubes) with trypsin (Gibco, 0.0025% 
and 0.00375% respectively for the myoblasts and myotubes). At 
the end of the process, nuclei were permeabilized with 0.2% Triton 
X-100 for 5 min. After centrifugation at 250 g for 3 min at + 4°C, 
nuclei were washed with ISO Buffer (10 mM K-Hepes (pH 7,5), 
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25 mM KCl, 2 mM MgCl2, 75 mM sucrose, 0,01% of NP-40 
(nonyl phenoxypolyethoxylethanol)) and centrifuged at 900g at + 
4°C for 3 min. Nuclei were counted (throught Burker chambers) 
and supplemented with 10% DMSO (dimethylsulfoxide).  They 
were, then, stored at -80°C.  
 
7.11.  DNA EXTRACTION 
 
DNA was purified using the QIAamp genomic DNA Kit (Quiagen) 
according to the manufacturer's instructions. The protocol was 
modified adding a step of  RNA digestion with Rnasi 1 µg/ml. 
DNA was quantified with the spectrophotometer Nanodrop (Termo 
Scientific). 
 
7.12.  REPLICATION ASSAY IN XEE 
 
The genomic material (nuclei or DNA) was added to a mix 
(replication mix) consisting of: 
 
30 µl XEE 
2 µl energy mix (20x; 0,2 mg/ml creatine 
phosphokinase (Sigma), 2 mg/ml phosphocreatine 
(Sigma), 20 mM MgCl 2, 2 mM EGTA) 
2 µl dTTP-3H( Perkin Elmer, 1 mCi)  
or 2 µl Biotin-16-dUTP (Roche, 1 mM)  
 
The mix was incubated at 23°C for the time of interest. 
 
7.13.  DNA REPLICATION QUANTIFICATION IN XEE 
 
16 µl of Stop Buffer (80 mM di Tris-HCl (pH 8), 8 mM di EDTA 
(pH 8), 0,1% H3PO4, 5% SDS, 50% Glycerol, 0.025% Blue-
Bromofenolo, 1 mg/ml Proteinasi K, 200 μg/ml Rnasi) were added 
to 4µl from the replication mix (see ‘replication assay in XEE’). 
The samples were incubated overnight at 37°C. 
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For radioactive material: the samples were transfered on glass 
microfilters (Whataman GF/C 2.5). The filters were incubated with 
5% cold trichloroacetic acid (TCA) and 2% cold inorganic 
pyrophosphate (PPi) for 20 min at +4°C. After 4 washings in 5% 
cold TCA, the samples were treated with 100% ethanol and 
transfered to vials with liquid scintillation (Optifluor, Perkinelmer). 
Radioactivity (index of the quantitiy of DNA replicated) was 
evaluated with Betacounter (Beckman). The protocol of Menut et 
al., 1999, was used to quantity the DNA replicated.  
For biotinylated material: the samples were transfered on a 
membrane (Optitrain BA-S 85”, 0,45 μm ) throught a dot blot 
microfiltration apparatus (BIO-RAD). The membrane was washed 
with 0,16M HCl for 3 times. The membrane was crosslinked 
(+80°C for 2 hours) and incubated with 1% Bovine Serum 
Albumin (BSA, Sigma) for 1hour. Streptavidin-Peroxidase from 
Stepromyces avicinii (Sigma, 1:10.000) coupled to horseradish 
peroxidase (HRP) was used to detect biotinylated material. The 
membrane was later treated with WesternBright ECL and 
visualized throught the ImageQuant Las 4000 (EG Healthcare). 
The densitometric analyses were made with ImageJ (NIH 
software). 
 
7.14. VISUALIZATION OF REPLICATING NUCLEI IN 
FLUORESCENCE 
 
1µl of Cy3-dCTP (GE Healthcare, 25nmol) (mixed to the 
replication mix) was used to follow the replication kinetics. At 
different time points 5µl from the samples were taken and mixed 
with 5µl of XEE fixative (3x Buffer A (45 mM Pipes pH 7,2 + 45 
mM NaCl + 240 mM KCl), 4% formaldehyde, 0,02 mg/ml DAPI, 
50% glycerol). Samples were transfered on cover slips. Nuclei 
were visualized using an Axioskop 2 Plus fluorescence microscope 
(see ‘DNA quantitation and γ-H2AX expression’). The percentage 
of nuclei incorporating Cy3-dCTP was counted.  
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7.15.  SALTING OUT WITH NaCl 
 
Nuclei were treated with 1M NaCl for 10 min. To remove NaCl, 
samples were washed with ISO Buffer (see ‘Nuclei Preparation’) 
and centrifugated at 250 g for 3 min.  
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